Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug - Alexander I. P. Taylor; Yong Xu; Martin Wilkinson; Pijush Chakraborty; Alice Brinkworth; Leon F. Willis; Anastasia Zhuravleva; Neil A. Ranson; Richard Foster; Sheena E. Radford (Journal of the American Chemical Society, 2025)